Voting Rights and Shares Capital Overview
The voting rights associated with shares are vital for any company aspiring to engage its shareholders actively. This is particularly true for innovative companies like Nanobiotix, which is pushing the boundaries of biotechnology. Understanding how many shares are outstanding and the total voting rights forms the basis of shareholder engagement and transparency.
Details of Shares and Voting Rights
On a specific date, Nanobiotix reported key figures regarding its outstanding shares and voting rights. The reported total number of outstanding shares was approximately 48,236,771. This figure is significant as it helps ascertain the overall equity in which shareholders have a stake.
Breaking Down Voting Rights
Total voting rights are divided into two categories: theoretical and exercisable. The theoretical voting rights were reported to amount to 50,337,954, while exercisable voting rights totaled 50,315,836. These numbers reflect the potential influence shareholders wield over company decisions, particularly during significant corporate actions such as annual meetings or strategic pivots.
About Nanobiotix
Nanobiotix is not just another biotechnology firm; rather, it is a late-stage clinical company that is revolutionizing treatment methodologies through a physics-based approach. Since its inception in 2003 and its public listing in 2012 on Euronext Paris and subsequently on the Nasdaq Global Select Market since December 2020, Nanobiotix has focused on enhancing the lives of countless patients.
Innovative Approaches to Healthcare
The company is known for its three pioneering nanotechnology platforms that focus on oncology, bioavailability, and diseases affecting the central nervous system. By emphasizing disruptive technologies, Nanobiotix is aiming to change the healthcare landscape fundamentally.
Contacting Nanobiotix
For those interested in exploring partnerships, investments, or media inquiries with Nanobiotix, several avenues for communication exist. The communications and investor relations departments are well-equipped to manage inquiries and provide additional details about the company's mission and vision.
Investor Engagement
The investor relations team, consisting of experts like Joanne Choi and Ricky Bhajun, is dedicated to ensuring that shareholders receive timely information related to their investments. They facilitate trust and transparency by clearly communicating company performance and strategic directions.
Frequently Asked Questions
What is the significance of voting rights in a company?
Voting rights allow shareholders to participate in decision-making processes that can significantly influence the company's direction.
How does Nanobiotix ensure transparency with its shareholders?
By regularly reporting on shares outstanding and voting rights, Nanobiotix keeps its shareholders informed about their stakes and the control they have within the company.
Where is Nanobiotix headquartered?
Nanobiotix is headquartered in Paris, France, with additional operations in key locations such as Cambridge, Massachusetts.
What are the main therapeutic areas Nanobiotix focuses on?
Nanobiotix specializes in oncology, bioavailability, biodistribution, and disorders of the central nervous system, aiming to innovate treatment methodologies.
How can investors contact Nanobiotix?
Investors can reach out to the investor relations department via the provided contact information for inquiries related to investments and company performance.
